According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still ...

Metformin treatment in type 1 diabetes lowers insulin dosage but does not improve insulin resistance, highlighting its ...

Global Insulin Delivery Device Market Growth Overview The global insulin delivery device market is poised to expand at a CAGR of around 8% during the forecast period, driven by the increasing global ...

A new polymer reported in Nature may mark a turning point for needle-free insulin delivery. Researchers at Zhejiang University have developed a charge-shifting polyzwitterion that can carry insulin ...

Vande Vegte was diagnosed at 19 while attending San Diego State University, a moment he describes as life-changing and completely unexpected.

A suite of products promise smoother skin, bigger muscles and longer life. But what are peptides? And do they work?

Type 1 diabetes is the second most prevalent kind of diabetes and can affect anybody; however, it is more frequent in children under 30. It is mostly an autoimmune illness in which our immune system ...

The government shutdown has ended without resolving a fight over health insurance. Congress failed to extend enhanced tax ...

According to DataM Intelligence, the U.S. Software as a Medical Device (SaMD) Market Size reached USD 205.12 million in 2024 ...

The U.S. Centers for Medicare & Medicaid Services (CMS) rolled out the negotiated costs of the second batch of drugs subject to such bargaining. CMS said the adjusted maximum fair prices would have ...